Trials Sponsors Conditions Drugs Pricing

Conditions

Periodontal Diseases

Keywords

I-PRF, thin gingival phenotype low level laser

Outcome Measures

Primary Outcomes (2)

Gingival thickness improvement in millimeters.
clinical parameter
6 months after treatment
Keratinized tissue width improvement in millimeters.
Clinincal parameter.
6 months after treatment

Secondary Outcomes (3)

Improvement of gingival index.
6 months after treatment
Improvement of bleeding on probing.
6 months after treatment
Improvement of sulcus depth.
6 months after treatment

Study Arms (2)

Test group: injectable platelet rich fibrin+ low level laser therapy

ACTIVE COMPARATOR

patients with thin gingival phenotype (gingival thickness less than 1mm) recieve I-PRF+LLLT radiation just after the injection for 3 sessions with 7 days interval between the sessions.

Other: injecable platelet rich fibrin, and low level laser therapy radiation.

Control group :I-PRF group

ACTIVE COMPARATOR

patients with thin gingival phenotype received I-PRF alone in 3 sessions, with 7 days interval between the sessions.

Biological: Biologic Agent: injectable platelet rich fibrin.

Interventions

Biologic Agent: injectable platelet rich fibrin.Biological

injection of I-PRF to thin gingival phenotype 3 times with 7 days interval between sessions.

Also known as: Liquid platelet rich fibrin

Control group :I-PRF group

injecable platelet rich fibrin, and low level laser therapy radiation.Other

injection of I-PRF+ exposure to LLLT to thin gingival phenotype 3 times with 7 days interval between sessions.

Eligibility Criteria

Age18 Years - 40 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64)

You may qualify if:

free systimatically good oral hygiene gingival thickness less than 1mm

You may not qualify if:

Sponsors & Collaborators

Faculty of Dental Medicine for Girls
Governmentlead

Study Sites (1)

Alaa Elsayed

Cairo, Egypt

MeSH Terms

Conditions

Periodontal Diseases

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic Diseases

Study Officials

Ahmed Eldawy, doctor
MINDRAY
PRINCIPAL INVESTIGATOR

Enrollment

7 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: phase 3
Allocation: RANDOMIZED
Masking: SINGLE
Who Masked: PARTICIPANT
Masking Details: I-PRF biologic product
Purpose: PREVENTION
Intervention Model: PARALLEL
Sponsor Type: OTHER GOV
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: periodontist

Study Record Dates

First Submitted

June 21, 2024

First Posted

January 3, 2025

Study Start

September 12, 2023

Low-Level Laser Therapy and Injectable Platelet-Rich Fibrin for Thin Gingival Phenotype.

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (3)

Study Arms (2)

Test group: injectable platelet rich fibrin+ low level laser therapy

Control group :I-PRF group

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (2)

Secondary Outcomes (3)

Study Arms (2)

Test group: injectable platelet rich fibrin+ low level laser therapy

Control group :I-PRF group

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Data Sharing

Source record

Locations